CellCarta Executive and Leadership Team

Dusty Tenney, the Chief Executive Officer at CellCarta, directs the overarching corporate strategy and operational execution. This leadership role involves guiding the organization's expansion within the biopharmaceutical industry, ensuring alignment with the company's mission to advance precision medicine through comprehensive biomarker solutions. Tenney oversees the integration of diverse biomarker platforms and services, driving innovation and client partnerships. The Chief Executive Officer's focus remains on maximizing the company's impact as a global Contract Research Organization Laboratory (CRO), addressing complex scientific testing needs. By fostering a culture of scientific excellence, Dusty Tenney ensures CellCarta delivers customized biomarker testing solutions that unlock the limitless potential of its clients' research and development efforts. This strategic direction solidifies CellCarta's position as a leader in supporting cutting-edge biopharmaceutical advancements.

Elliott Miller, the Chief Financial Officer at CellCarta, directs all financial planning, accounting, and reporting functions for the organization. This executive leadership ensures robust fiscal management, supporting CellCarta's operations as a global Contract Research Organization Laboratory (CRO) serving the biopharmaceutical industry. Miller oversees budgeting, forecasting, and financial analysis, providing critical insights to guide strategic decision-making and resource allocation. The Chief Financial Officer's role is integral to maintaining financial stability and driving profitable growth, enabling the company to invest in advanced biomarker platforms and services. By managing financial risks and optimizing capital structure, Elliott Miller supports CellCarta's commitment to delivering customized biomarker testing solutions for precision medicine. This financial oversight is essential for the company's sustained success and expansion in addressing complex scientific testing needs.

Anthony Mattacchione, the Global Chief Financial Officer at CellCarta, oversees the comprehensive financial operations and strategic fiscal direction across all international markets. This executive leadership ensures consistent financial integrity and performance for CellCarta's global Contract Research Organization Laboratory (CRO) services within the biopharmaceutical sector. Mattacchione directs global accounting standards, treasury functions, and investor relations, driving financial strategies that support the company's expansive reach. The Global Chief Financial Officer's purview includes optimizing financial resources to enhance the delivery of advanced biomarker platforms and services worldwide. By implementing rigorous financial controls and identifying growth opportunities, Anthony Mattacchione strengthens CellCarta's capacity to provide customized biomarker testing solutions essential for precision medicine. This global financial stewardship is paramount to addressing complex scientific testing needs on an international scale.

Louis Norton, the Chief Information Officer at CellCarta, architects and manages the company's entire technology infrastructure and digital strategy. This critical function ensures the secure and efficient operation of all IT systems, supporting CellCarta's role as a global Contract Research Organization Laboratory (CRO). Norton oversees the implementation of advanced data management solutions, crucial for handling the complex scientific testing needs inherent in biomarker research. The Chief Information Officer's responsibilities extend to safeguarding sensitive client data and ensuring compliance with industry regulations. By driving technological innovation, Louis Norton enables the seamless delivery of customized biomarker testing solutions, directly supporting the advancement of precision medicine. This leadership ensures that CellCarta's technological capabilities consistently meet and exceed the demands of the biopharmaceutical industry, facilitating groundbreaking research.

Ehab ElGabry, the Chief Medical Officer at CellCarta, provides critical medical and scientific leadership, guiding the company's strategic direction in biomarker research and development. This role is central to CellCarta's mission as a global Contract Research Organization Laboratory (CRO) dedicated to advancing precision medicine within the biopharmaceutical industry. ElGabry oversees the scientific integrity of biomarker platforms and services, ensuring their alignment with cutting-edge research and clinical applications. The Chief Medical Officer's expertise is vital in interpreting complex scientific testing needs and translating them into effective, customized biomarker testing solutions. By fostering scientific collaboration and innovation, Ehab ElGabry ensures CellCarta remains at the forefront of addressing the most challenging scientific questions, driving progress in personalized healthcare. This medical leadership underpins the company's commitment to unlocking the full potential of precision medicine for its partners.